CHIL Connects Globally at MEDICA
Between November 14 and 17, 2022, CHIL participated in MEDICA Messe Düsseldorf, one of the world’s most prominent medical technology…
Senay Cil Elected President of Aegean Region Medical Industry Committee
Senay Cil, one of our company’s partners, has been elected President of the Aegean Region Medical Industry Committee (EBSO), reinforcing…
CHIL Makes Its Mark in the USA
From July 26 to 28, 2022, CHIL participated in the AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago,…
CHIL Partners with Bakırçay University to Drive Innovative R&D
On 19 July 2022, Senay Cil, Partner at CHIL, signed a university-industry cooperation protocol with Bakırçay University, establishing a framework…
CHIL Receives CE Certification for COVID-19 Antigen Test
On 28 April 2022, CHIL successfully obtained CE certification for its COVID-19 Antigen Test after completing a comprehensive audit conducted…
CHIL Invests in Permanent 6,000 m² Production and Management Facility
On 18 February 2022, CHIL took a significant strategic step by acquiring a 6,000 m² production and administrative facility, strengthening…
CHIL Highlights Its Role in Middle East Diagnostics
From January 24 to 27, 2022, CHIL attended Medlab Middle East in Dubai, engaging directly with regional leaders and laboratory…
CHIL Showcases Diagnostic Innovation Amid Evolving Global Challenges
At MEDICA Messe Düsseldorf, from November 15 to 18, 2021, CHIL participated in one of the world’s most significant medical…
CHIL Achieves GMP Certification
On 1 November 2021, CHIL added a significant milestone to its growing portfolio of national and international approvals by achieving…
CHIL Engages in a Dynamic Middle East Diagnostics Landscape
During Medlab Middle East in Dubai, held from June 21 to 24, 2021, CHIL actively engaged with regional stakeholders in…